Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA

NCT04197414 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT04197414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04197414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Recruiting
Start date
December 6, 2019
Completion date
December 31, 2029
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, prostate cancer, renal cell cancer, ureter cancer